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Abstract
Background: Accurate data on childhood pneumonia aetiology are essential especially from regions where mortality is
high, in order to inform case-management guidelines and the potential of prevention strategies such as bacterial conjugate
vaccines. Yield from blood culture is low, but lung aspirate culture provides a higher diagnostic yield. We aimed to
determine if diagnostic yield could be increased further by polymerase chain reaction (PCR) detection of bacteria
(Streptococcus pneumoniae and Haemophilus influenzae b) and viruses in lung aspirate fluid.
Methods: A total of 95 children with radiological focal, lobar or segmental consolidation had lung aspirate performed and
sent for bacterial culture and for PCR for detection of bacteria, viruses and Pneumocystis jirovecii. In children with a
pneumococcal aetiology, pneumococcal bacterial loads were calculated in blood and lung aspirate fluid.
Results: Blood culture identified a bacterial pathogen in only 8 patients (8%). With the addition of PCR on lung aspirate
samples, causative pathogens (bacterial, viral, pneumocystis) were identified singly or as co-infections in 59 children (62%).
The commonest bacterial organism was S.pneumoniae (41%), followed by H. influenzae b (6%), and the commonest virus
identified was adenovirus (16%), followed by human bocavirus (HBoV) (4%), either as single or co-infection.
Conclusions: In a select group of African children, lung aspirate PCR significantly improves diagnostic yield. Our study
confirms a major role of S.pneumoniae and viruses in the aetiology of childhood pneumonia in Africa.
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Introduction
Pneumonia is the major cause of death in children throughout the
developing world especially in children under the age of 5 years [1].
Most deaths attributable to acute respiratory infection are caused by
pneumonia and bronchiolitis [2]. Data of the causes of pneumonia are
required from regions where deaths due to pneumonia are common,
in order to inform case-management guidelines and the potential of
prevention strategies such as bacterial conjugate vaccines [3].
An inherent difficulty with pneumonia aetiology studies is the
low yield from blood culture. Lung aspiration with culture
provides a higher diagnostic yield and is more specific for
causative pathogen than blood culture. Lung aspirate is safe and
provides reliable diagnostic information [4].
Lung aspirate studies have contributed significantly to our
understanding of the bacterial aetiology of pneumonia, and data
from these studies provided the important evidence base for the
case-management strategy recommended by the World Health
Organization (WHO) [2]. However, as is the case for blood
culture, the yield from lung aspirate culture is likely to be affected
by prior antibiotic usage, especially for the more fastidious
organisms, such as Streptococcus pneumoniae. PCR of lung aspirate
fluid increases the yield further [5], [6] especially in patients who
have received antibiotics [7].
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uncertain as most studies utilise nasopharnygeal aspirates, and it is
therefore difficult to imply causation as virus detection in the
nasopharynx may simply reflect colonisation [8]. In South African
children, viral pathogens were identified less frequently than
bacterial pathogens in HIV-infected children, and HIV-infected
children with severe viral lower respiratory tract infections
(LRTI) had higher mortality than HIV-uninfected children [9].
In children under 2 years of age with LRTI, most pathogens
identified were predominantly RSV, Influenza A+B, Parainfluen-
zae 1–3 and adenovirus. Polymicrobial disease has been identified
as a major cause of treatment failure in children under 5 years of
age in South Africa [10].
We performed lung aspiration on a select group of Malawian
children as part of a larger descriptive study examining the
cytokine profile and genetic determinants of invasive pneumococ-
cal disease. Here, we report the use of PCR for detection of
Streptococcus pneumoniae, Haemophilus influenzae type b (Hib), Myco-
plasma pneumoniae, Chlamydia pneumoniae, Pneumocystis jirovecii and nine
respiratory viruses: Respiratory Syncytial Virus (RSV), Human
metapneumovirus (hMPV), Influenza A and B, Parainfuenza virus
1–4, Coronavirus (HKU-1, NL63, OC43), Rhinovirus, Adenovi-
rus, and Human Bocavirus (HBoV) in lung aspiration specimens,
and we compare diagnostic yield for bacteria between PCR
applied to lung aspirate and bacteriological culture of blood and
lung aspirate fluid. We show that PCR of lung aspirate fluid
increases diagnostic yield.
Results
Study population characteristics
During the study period, we screened 424 children with a clinical
diagnosis of pneumonia by chest radiographs, of which 95 had
lobar, focal, or segmental consolidation. We recruited 95 children
between 1 April 2004 and 31 October 2006. The median age was
2.6 years, interquartile range (IQR) 1.0–5.7 years. Of the total, 58
were male (61%), 59 (62%) were HIV-infected, and 6 died (6.3%).
Characteristics of children with radiologically confirmed pneumo-
nia are shown in Table 1.
Of the 89 cases in whom immunisation was completely recorded,
82 (92%) were reported to have completed 3 doses of primary
immunisation, including Hib. Cases presented throughout the year,
but the peak of pneumonia cases occurred between August and
November, the hot dry season.
Pathogens identified by culture or PCR
A pathogen (bacterial, viral, pneumocystis) was identified in 59
children (62%), either singly or as co-infection. Only 10 samples in
9 patients (9%) were positive by culture; 8 by blood culture and 2
by lung aspirate culture. The aetiological agents are listed in
Table 2. The commonest bacterial organism was S.pneumoniae
(41%), followed by H. influenzae b (6%), and the commonest virus
identified was adenovirus (16%), followed by human bocavirus
(HBoV) (4%), either as single or co-infection. In total, 3 out of the
4 children with HBoV were aged over 5 years. The infant with
HBoV infection was 6 months old, co-infected with CMV and was
also HIV-infected. Two of the 3 children with viral co-infections
were HIV-infected. Bacterial/viral co-infection occurred in 9
children (9%), of whom 4 (44%) were HIV-infected, and the
commonest was S pneumoniae/adenovirus (7 cases). Four out of six
of the Hib cases were HIV-infected. P.jirovecii was identified in 3
infants. All were HIV-infected, less than 6 months of age, co-
infected (with Hib, adenovirus and C. pneumoniae respectively) and
all died. Four out of 6 of the children with Hib pneumonia were
fully immunised, one had received only one dose and in one there
was no record of immunisation status.
Blood culture was positive in only 8 children, 6 with S.pneumoniae
and 2 with Salmonella typhimurium. Lung aspirate culture was
positive in 2 children, one with S.pneumoniae (blood culture
negative) and one with S. typhimurium (blood culture positive). In
total 14/95 (15%) of children were bacteraemic by blood culture
or blood PCR for pneumococcus or Hib. There was no reported
prior antibiotic usage in the two cases that were lung aspirate
culture positive, but one of them had received the antimalarial
sulphadoxine-pyrimethamine prior to admission. Prior antibiotics
were reported in 23/36 (64%) with bacteria identified by PCR and
Table 1. Characteristics of children with radiologically
confirmed pneumonia.
Characteristic Number (%) n=95
Age
2–5.99 months 9 (9.5%)
6–11.99 months 14 (14.7%)
1–4.99 years 45 (47.4%)
5–9.99 years 20 (21.1%)
10–15 years 7 (7.4%)
Males 58 (61%)
Deaths 6 (6.3%)
Median age- years (IQR) 2.6 (1.0–5.7)
Median duration of symptoms- days (IQR) 4 (3–7)
Median duration of hospital stay- days (IQR) 4 (3–5)
Prior treatment
Antibiotics 49 (52%)
Penicillin 20
Cotrimoxazole therapy 15
Of which, on prophylaxis 3
Gentamicin 9
Amoxycillin 4
Erythromycin 3
Chloramphenicol 2
Flucloxacillin 1
Don’t know antibiotic 2
Antimalarials 13 (14%)
SP 12
Quinine 1
Clinical features
Temperature .38uC 62/95 (65%)
Median temperature - uC (IQR) 38.7 (37.7–39.2)
Increased work of breathing 66/92 (72%)
Grunting 45/95 (47%)
Crackles 72/93 (77%)
Hypoxia (O2 saturation,90%) 17/90 (19%)
Median O2 saturation % (IQR) 94 (90–96)
Oxygen therapy 28/91 (31%)
HIV-infected 59 (62%)
Wasting (wt-for-ht Z score,23) 17/76 (9.2%)
Stunting (ht-for-age Z score,23) 20/91 (22%)
doi:10.1371/journal.pone.0021042.t001
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squared test). Children with a confirmed bacterial pneumonia
(either singly or co-infected), were significantly less likely to have
signs of grunting or require oxygen therapy than children without
confirmed bacterial pneumonia (Table 3).
Pneumococcal bacterial loads
For children with positive lung aspirate or blood PCR for
pneumococcal DNA, pneumococcal bacterial loads were avail-
able. Lung aspirate bacterial loads (n=31) ranged from 2.19610
2
to 1.6610
8 copies/ml, median 1.25610
4, IQR 2.22610
3–
1.22610
5 copies/ml. Blood bacterial loads (n=11) ranged from
1.22610
2 to 1.54610
6 copies/ml, median 3.36610
2, IQR
1.60610
2–1.62610
3 copies/ml. Blood and lung aspirate median
bacterial loads were higher in non-survivors than in survivors, but
these differences were not significant (Blood: 11,047 versus 283
copies/ml and lung aspirate: 247,217 versus 10,869 copies/ml
respectively). Lung aspirate bacterial loads were lower in HIV-
infected children and blood bacterial loads were higher, but these
differences were not significant (Lung aspirate: 8,986 versus 39,859
copies/ml and blood: 831 versus 283 copies/ml respectively).
There was no correlation between lung and blood bacterial loads.
Complications and outcome
Following lung aspiration, two patients (2%) had a pneumo-
thorax on the same side as the aspiration. One presented with
worsening respiratory distress about 4 hours after aspiration. A
large tension pneumothorax was diagnosed. An intercostal chest
Table 2. Aetiology of radiologically confirmed pneumonia.
No HIV+ (%) Blood culture Lung aspirate culture Lung aspirate latex Lung aspirate PCR
Bacterial aetiology
Total 45 8 2 4 36
S.pneumoniae 37 68% 6 1 3 31
S.pneumoniae/S.typhimurium 20 % 2 1 0 N T
H.influenzae type b 6 67% 0 0 1 5
Viral aetiology
Total 24 NT NT NT 24
Adenovirus 15 53% NT NT NT 15
Bocavirus 4 50% NT NT NT 4
Cytomegalovirus 3 100% NT NT NT 3
Atypical
Chlamydia pneumoniae 20 % N T N T N T 2
Mycoplasma pneumoniae 0N T N T N T 0
Pneumocystis jirovecii 31 0 0 % N T N T N T 3
NT: not tested, PcP: pneumocystis pneumonia, Hib: Haemophilus influenzae b, CMV: cytomegalovirus.
Bacteria: 2 patients had mixed infection with S.typhimurium and S.pneumoniae ;1h a dS.typhimurium from blood culture and S.pneumoniae from blood PCR, and
adenovirus from lung aspirate PCR, 1 had S.typhimurium from blood and lung aspirate culture and S.pneumoniae from lung aspirate PCR, 7 had S.pneumoniae/
adenovirus, 1 had S.pneumoniae/Chlamydia, 1 case with S.pneumoniae had M. tuberculosis cultured from nasopharyngeal aspirate after induced sputum.
Pneumocystis: 1 patient had PcP/Hib, 1 patient had PcP/CMV, 1 patient had PcP/adenovirus.
Viruses: 1 adenovirus/CMV, 1 adenovirus/Chlamydia, 1 bocavirus/CMV.
doi:10.1371/journal.pone.0021042.t002
Table 3. Clinical variables in children with confirmed bacterial pneumonia and children with pneumonia without bacterial
confirmation.
Clinical features Bacterial aetiology Other aetiology p value
Increased work of breathing 31/45 (69%) 35/47 (75%) NS
Grunting 17/46 (37%) 28/49 (57%) 0.05
Crackles 32/45 (71%) 40/48 (83%) NS
Oxygen therapy 8/45 (18%) 20/46 (44%) 0.008
Temperature.38uC 28/46 (61%) 34/49 (69%) NS
Oxygen saturation,90% 4/42 (10%) 13/48 (27%) 0.06
Wasting (wt-for-ht Z score,23) 4/35 (11%) 3/41 (7%) NS
Stunting (ht-for-age Z score,23) 11/45 (24%) 9/46 (20%) NS
Death 2/46 (4%) 4/49 (8%) NS
NS=not significant.
doi:10.1371/journal.pone.0021042.t003
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crescent of air in the pleural space detected on post-aspiration
CXR and did not require further management.
Six children died, and all were HIV-infected. Three had PcP
identified with co-infections and the other three without PcP were
severely malnourished: one aged 1.4 years had a height-for-age Z
score of 24.3 and a weight-for-height Z score of 22.4 and
developed convulsions during his hospital stay; one aged 6 months
had co-infection with HBoV and CMV and had a height-for-age Z
score of 23.1; one aged 1.3 years had kwashiorkor, was infected
with S.pneumoniae, and had a weight-for-height Z score of 22.3.
Discussion
We have demonstrated that lung aspirate PCR significantly
improves the diagnosis of radiological pneumonia from 9/95
(10%) identified by blood and lung aspirate culture to 59/95 (62%)
identified by blood and lung aspirate culture and lung aspirate
PCR. Co-infection occurs commonly in both HIV-infected and
HIV-uninfected children. We provide the first report of HBoV
detected from lung aspirate samples in children with radiologically
confirmed pneumonia.
The strengths of our study were that we performed PCR to
improve diagnosis of both viral and bacterial aetiologies. We
performed lung aspirate culture and PCR as well as blood culture;
most studies of pneumonia aetiology have previously only used
blood culture to identify bacterial aetiologies. Lung aspiration was
performed in a select group of children with pneumonia (22%),
therefore our findings do not necessarily represent the spectrum of
aetiology of radiological pneumonia in this population. Selecting
only children with focal, lobar or segmental consolidation meant
that most cases of PcP were likely to be excluded, which probably
accounts for the lower overall case fatality rate in our study than
has been reported in comparable studies [11]. The median age of
our group was higher than that of children with pneumonia
presenting to Queen Elizabeth Central Hospital [11]; pathogens
that commonly occur in infants such as RSV and PcP may
therefore be under-represented in our study. Lung aspirate PCR
was only designed to identify a small number of bacteria, and did
not identify Gram negative organisms such as Klebsiella or non-
typhoidal salmonella. Validated PCR assays for Klebsiella or non-
typhoidal salmonella or Staphylococcus aureus were not available in
our laboratory.
The finding that PCR was much more sensitive than culture in
children who had lung aspiration performed is likely to reflect the
frequent use of antibiotics prior to presentation as well as the
inherent increased sensitivity of the test over culture. The fact that
urine was not tested for antibiotic activity may have resulted in a
significant under-reporting of previous antibiotic exposure, and
may have contributed to the low culture positivity rate despite
positive bacterial PCR. An organism identified in a sample
obtained directly from consolidated lung is more likely to be the
causative agent than are organisms retrieved from samples such as
from nasopharyngeal aspirates and even from bronchoalveolar
lavage because of the risk of contamination of these samples with
carriage isolates [8]. Nasopharyngeal carriage of pneumococcus is
very common among well infants in regions such as Malawi [12].
A limitation of RT-PCR compared to culture is that it does not
provide antibiotic susceptibility data. Serotype data can now be
provided from lung aspirate samples using Luminex technology
[13], or PCR [14], [15] but these assays were not available to us at
the time of the study.
There are now over 35 reported studies of pneumonia in
children where lung aspirate has been used [4], [5], [6], [10]. In
the review of the published series up to 1999 the pneumothorax
complication rate was 3.3%. There are seven deaths reported from
6001 lung aspirates, a mortality of approximately 1 in 850,
although the deaths were not thought to be directly attributable to
lung aspiration [4]. Our data are consistent with a study from
Finland using lung aspirate for the diagnosis of childhood
pneumonia, in which lung aspirate disclosed the aetiology in
59% [6]. That study however had a significantly higher
complication rate, with pneumothorax developing in 18% of
children, compared with the complication rate in our study of 2%.
It must be emphasized that lung aspiration is not recommended in
a child suspected to be suffering from PcP, because of the
increased risk of pneumothorax [16]. The relatively low number of
cases with Hib pneumonia reflects the effect of Hib immunisation
in the primary immunisation schedule.
HBoV has been associated with clinical illness in many studies,
but it often occurs as a co-infection [17], [18]. This has led to the
debate as to whether HBoV is a true pathogen or an innocent
bystander. A recent study by Don et al. [19] suggests that the host
immune system recognises HBoV as a pathogen by eliciting
significant antibody responses. HBoV has also been associated
with pneumonia requiring hospitalization in young children in
Thailand [20]. Our study is the first study to report HBoV
detection in lung aspirate samples in children with radiological
pneumonia, strongly suggesting that the infection arose from the
lower airways as opposed to merely colonising the nasopharynx. A
recent study from Finland found high concentrations of HBoV in
induced sputum, also suggesting that the virus may have
originated from the lower airways [21].
In a recent study from Kenya, 56% of infants and children
who presented with severe pneumonia had one or more
respiratory viruses detected on nasal wash samples by PCR
[22]. In that study, 4.7%of children were bacteraemic, compared
to 15% in our study. In another recent study from Mozambique,
49% of nasopharyngeal aspirate samples from children under 5
years with severe pneumonia had at least one respiratory virus
detected by PCR [23]. Viral infection was more prevalent
in HIV-infected children, and in-hospital mortality was highest in
children with invasive bacterial co-infection and HIV infection
[23]. Given that all the children reported in these studies fulfilled
the WHO criteria for severe pneumonia, and would therefore
have received parenteral antibiotics, there is now an urgent
need for reliable, affordable point of care diagnostics to help
differentiate bacterial from viral aetiologies in an attempt to
promote judicious antibiotic prescribing. We previously reported
the performance of five diagnostic biomarkers to predict serious
bacterial infection (SBI) in African children [24]. In the current
study reported here, median C-reactive protein and procalcitonin
levels on admission were significantly higher in children with
confirmed bacterial pneumonia than in children with pneumonia
without bacterial confirmation, but there was a degree of overlap
(data not shown). A larger study assessing the performance of
biomarkers of SBI in all children presenting with severe
pneumonia is now indicated, augmented by molecular diagnostic
testing to enhance diagnosis of bacterial infection. This will allow
a more accurate prediction of the utility of biomarkers to guide
antibiotic prescribing.
We have shown that lung aspirate PCR significantly increases
diagnostic yield in children with focal, segmental or lobar
consolidation. In keeping with recent studies from the developing
world using PCR for virus detection, our study adds to the growing
body of evidence that S.pneumoniae and respiratory viruses
contribute significantly to the aetiology of childhood pneumonia
in Africa. We provide the first report of HBoV from lung aspirate
Lung Aspirate PCR Improves Pneumonia Diagnosis
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confirmed pneumonia.
Methods
Ethics statement
Ethical approval was obtained from both The College of
Medicine Research and Ethics Committee and the Liverpool
School of Tropical Medicine Research and Ethics Committee.
Information was provided in English and Chichewa. Written
consent was obtained from all participants.
Study patients and procedures
A prospective, observational study of the cytokine profile and
genetic determinants of invasive pneumococcal disease (children
presenting with pneumonia or meningitis) was undertaken at
Queen Elizabeth Central Hospital (QECH), Blantyre, between 1
st
April 2004 and 30
th October 2006. The details of the study
participants and recruitment procedures have been previously
reported [25], [26], [27]. All children screened for inclusion in the
present study had a clinical diagnosis of pneumonia only, and only
those with radiologically confirmed pneumonia with focal,
segmental or lobar pneumonia were enrolled. Routine immuni-
sation during the period of this study included neonatal BCG,
DPT-Hep B and Hib conjugate vaccine at 6, 10 and 14 weeks.
Hib vaccine was introduced in Malawi in 2002 and pneumococcal
conjugate vaccine was not available throughout the study period.
Clinical data collected on enrolment to the study following
written informed consent included prior or current treatment with
antibiotics or antimalarials. Chest radiographs were performed on
admission and only children with focal, lobar or segmental
consolidation were recruited. Arterial oxygen saturation (SpO2)
when breathing air was measured with pulse oximetry and
monitored regularly along with vital signs throughout the hospital
stay by nursing staff according to research ward protocols. Urine
was not tested for antibiotic activity. All children were reviewed by
the study clinicians at least twice per day.
Blood (1–2 ml) was taken for culture prior to commencement
of antibiotics and cultured using the BacT/Alert 3D automated
system (BioMerieux, France). All isolates were identified using
standard diagnostic techniques and antibiotic susceptibility was
tested using the Kirby-Bauer disk diffusion method. HIV testing
was done following a separate written informed consent with pre-
and post-test counselling provided by a trained nurse counsellor,
for those who accepted testing. HIV status was determined in all
patients. In children $18 months, HIV status was assessed using
at least two of the following tests; Unigold (Trinity Biotech,
Ireland), Serocard (Trinity Biotech, Wicklow, Ireland), or
Determine-HIV (Abbott Laboratories, Illinois, USA). In children
under 18 months, and those with discordant antibody tests, HIV
status was determined using Amplicor HIV-1 DNA (Roche
Diagnostics, USA).
Lung aspiration procedure
Single needle aspiration of consolidated lung was performed
prior to commencement of antibiotics in hospital after written
informed consent in patients that fitted select criteria: chest
radiograph immediately available showing an area of consolida-
tion adjacent to the chest wall, no hyperinflation and Pneumocystis
pneumonia (PcP) not suspected. Children with severe hypoxia
were not excluded. The area of consolidation was confirmed by
auscultation and percussion. After aseptic cleaning of the skin, a
23-guage needle attached to a 5 ml syringe containing 2 ml of
sterile normal saline was advanced into the area of consolidation.
The needle was removed whilst maintaining continuous suction
and the sterile saline in the syringe was used to facilitate removal of
the lung fluid and debris from the syringe and needle. A chest
radiograph was performed routinely after aspiration within one
hour, or at any other time when indicated if an air leak was
suspected. Paediatric chest drain kits with a range of sizes were
always available on the ward.
Lung aspirate fluid was cultured using the BacT/Alert 3D
automated system and the remainder of the sample was stored at
280uC until analysis. Bacterial DNA for H influenzae and S
pneumoniae was amplified and quantified using a real-time PCR
assay using capsulation (bexA), and pneumolysin (ply) gene targets
specific for, H. influenzae, and S. pneumoniae respectively using the
ABI 7700 Sequence detection system (Taqman), which has been
shown to improve non-culture diagnosis and case ascertainment
[25],[28]. Real-time quantitative PCR for CMV was performed
using the ABI 7500 Sequence detection system (Taqman) using
primers which have been previously described [29]. Real-time
PCR for Pneumocystis jirovecii amplified a section of the large sub-
unit of the mitochondrial RNA. Qualitative PCR was also
performed on the lung aspirate fluid for Respiratory Syncytial
Virus (RSV), Human metapneumovirus (hMPV), Influenza A+B,
Parainfuenza virus 1–4, Coronavirus (HKU-1, NL63, OC43),
Rhinovirus, Adenovirus, Chlamydia pneumoniae, Mycoplasma pneumo-
niae, and Human Bocavirus (HBoV). Briefly, RNA and DNA was
extracted using commercial kits (Qiagen, Basingstoke , UK).
Extracted RNA was used in a duplex RT-PCR method for RSV
nucleocapsid and hMPV matrix gene detection using primers
previously described [30], [31]. A multiplex influenza RT-PCR
was performed to identify Influenza A and B and a second
multiplex RT-PCR was utilized for the detection of parainfluenza
virus types 1–4 [32]. Adenovirus, Chlamydia and M. pneumoniae
were detected using previously published protocols [33]. The
HCoV genomes were amplified separately by RT-PCR using
previously published primers for; HCoV NL63 [34], HCoV
HKU1 [35], HCoV229E, and HCoVOC43 [36]. Bocavirus
detection used the primers published previously [37] and
rhinovirus detection used the multiplex method described by
Choi [36]. The multiplex PCR assays for these respiratory viruses
have been used by our group in previous studies [38], [39], [40].
Lung aspirate fluid was not cultured for Mycobacterium tuberculosis.
Definitions
Hypoxia was defined as SpO2 ,90%. Confirmed bacterial
pneumonia was defined as: Radiological evidence of pneumonia
(focal, segmental or lobar consolidation) plus one or more of the
following: blood or lung aspirate culture positive, lung aspirate
positive for pneumococcal polysaccharide antigen or Hib antigen
or PCR positive for S. pneumoniae or H. influenzae b. A cut-off value
of .100 copies/ml was used to determine a positive PCR in either
blood or lung aspirate. This cut-off value was used based on a
previous study using pneumococcal DNA to differentiate between
carriage and disease in cases and controls (Carrol ED,
unpublished).
Increased work of breathing: Recession, grunting, nasal flaring, or
use of accessory muscles of respiration.
Statistical analysis
Median levels of pneumococcal bacterial loads were compared
between two groups using the Mann-Whitney U test. Tests for
association between binary variables were performed using
Fisher’s exact test. Reported p values are two-tailed, and the 5%
significance level was used to infer statistical significance. Statistical
Lung Aspirate PCR Improves Pneumonia Diagnosis
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e21042Package for Social Sciences (SPSS), version 15.0 (Illinois, USA)
was used for all analyses.
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